17 results
SC14D9C
EX-2.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Written communication relating to third party tender offer
7:37am
) or, to the Company’s knowledge, has been adulterated or misbranded. No proceedings (whether complete or pending) seeking the recall, withdrawal
8-K
EX-2.1
PNT
POINT Biopharma Global Inc.
3 Oct 23
Tender and Support Agreement
7:35am
) or, to the Company’s knowledge, has been adulterated or misbranded. No proceedings (whether complete or pending) seeking the recall, withdrawal
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
or holder of an approved NDA, including recall. TABLE OF CONTENTS 32
The FDA may withdraw approval if compliance with regulatory requirements and standards … with authorized trading partners. In the event of a recall or an inquiry regarding a potentially illegitimate product, manufacturers must be able to provide
424B3
PNT
POINT Biopharma Global Inc.
31 Mar 22
Prospectus supplement
11:42am
manufacture or distribution;
POINT, or any future collaborators, may be required to recall the product, change the way such product is administered … recall.
The FDA may withdraw approval if compliance with regulatory requirements and standards is not maintained or if problems occur after
POS AM
PNT
POINT Biopharma Global Inc.
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
to recall the product, change the way such product is administered to patients or conduct additional clinical trials;
additional restrictions may … in restrictions on a product, manufacturer or holder of an approved NDA, including recall.
The FDA may withdraw approval if compliance with regulatory
424B3
rbek5tp42wexrp89
5 Aug 21
Prospectus supplement
4:26pm
424B3
7ph08h1dsjzsm3i12q2
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
EX-10.16
f0hxpxt4i
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
EX-10.19
wdda5kzd1 cz2
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
0ota9w5tqqsi9j6ce
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
EX-10.16
b8brjzo1x7i5gecbzq1
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
3fuhgqt68hlh0c
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
3y1ey
18 Mar 21
Financial Statements and Exhibits
9:08am
- Prev
- 1
- Next